Välkommen till slmf.se
Dessa sidor är till för Svensk Lungmedicinsk Förenings medlemmar och riktar sig endast till hälso- och sjukvårdspersonal
Dessa sidor är till för Svensk Lungmedicinsk Förenings medlemmar och riktar sig endast till hälso- och sjukvårdspersonal
SPARC (Swedish Pulmonary Alliance for Research Collaboration) är ett forskningsnätverk under SLMF för att stödja och genomföra svenska kliniska multicenterstudier inom lungmedicin.
Vid frågor eller intresse, kontakta: sparc@slmf.se
Beta-blockeRs tO patieNts with CHronIc Obstructive puLmonary diseasE
Academic, pragmatic, randomized, controlled, trial of added metoprolol compared with usual care only in people with chronic obstructive pulmonary disease (COPD) who do not have any cardiovascular indication for treatment with beta blocker. Primary composite outcome is cardiac event, exacerbation or death up to one year.
Coordinating Investigator: Josefin Sundh, Region Örebro County.
Protocol article, doi: 10.1186/s13063-019-3907-1
ClinicalTrials.gov, ID: NCT03566667
Effect of HIgh-flow Therapy in Long-term Oxygen Therapy
A multicenter, registry-based, randomized clinical trial of added high-flow oxygen therapy during nighttime compared with usual care (low-flow oxygen therapy) alone in patients on long-term oxygen therapy due to COPD or interstitial lung disease (ILD). Primary composite outcome is time to all-cause hospitalization or death up to one year. The trial is conducted in collaboration with ResMed.
Coordinating Investigator: Magnus Ekström, Region Skåne.
ClinicalTrials.gov, ID: NCT06247397
REgistry-based randomized controlled trial of treatment Duration and mortality in long-term OXygen therapy (REDOX)
Multicenter, phase IV, registry-Based, randomized controlled trial of long-term oxygen therapy prescribed for 24 hours/day compared with 15 hours/day. The trial is conducted using the Swedish Registry for Respiratory Failure (Swedevox). Primary composite outcome is time to all-cause hospitalization or death up to one year.
Coordinating Investigator: Magnus Ekström, Region Blekinge.
Protocol article, doi: 10.1186/s12890-019-0809-7.
ClinicalTrials.gov, ID: NCT03441204.
Main publication: https://pubmed.ncbi.nlm.nih.gov/39254466/
Validation of International Standard Tests for Exertional Breathlessness (VALIDATE)
Multicenter validation study of the two clinical tests, the 3-minute stepping and walking tests, to assess the intensity of breathlessness at standardized level of exertion, in people with asthma, COPD, ILD, heart failure, obesity, lung cancer, and healthy references.
Coordinating Investigator: Magnus Ekström, Region Blekinge.